201 related articles for article (PubMed ID: 36086447)
1. An Intra- and Inter-Modality Fusion Model Using MR Images for Prediction of Glioma Isocitrate Dehydrogenase (IDH) Mutation.
Shi X; Zhang X; Iwamoto Y; Cheng J; Bai J; Zhao G; Chen YW
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():198-202. PubMed ID: 36086447
[TBL] [Abstract][Full Text] [Related]
2. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
3. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
[TBL] [Abstract][Full Text] [Related]
4. Multi-task Model for Glioma Segmentation and Isocitrate Dehydrogenase Status Prediction Using Global and Local Features.
Shi X; Li Y; Cheng J; Bai J; Zhao G; Chen YW
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-5. PubMed ID: 38083206
[TBL] [Abstract][Full Text] [Related]
5. Deep wavelet scattering orthogonal fusion network for glioma IDH mutation status prediction.
Chen Q; Wang L; Xing Z; Wang L; Hu X; Wang R; Zhu YM
Comput Biol Med; 2023 Nov; 166():107493. PubMed ID: 37774558
[TBL] [Abstract][Full Text] [Related]
6. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.
Zhou W; Wen J; Huang Q; Zeng Y; Zhou Z; Zhu Y; Chen L; Guan Y; Xie F; Zhuang D; Hua T
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1423-1435. PubMed ID: 38110710
[TBL] [Abstract][Full Text] [Related]
8. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK
Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862
[TBL] [Abstract][Full Text] [Related]
9. Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.
Liu S; Shah Z; Sav A; Russo C; Berkovsky S; Qian Y; Coiera E; Di Ieva A
Sci Rep; 2020 May; 10(1):7733. PubMed ID: 32382048
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis.
Li Y; Qin Q; Zhang Y; Cao Y
Curr Oncol; 2022 Sep; 29(10):6893-6907. PubMed ID: 36290819
[TBL] [Abstract][Full Text] [Related]
11. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
[TBL] [Abstract][Full Text] [Related]
12. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
[TBL] [Abstract][Full Text] [Related]
13. Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.
Peng H; Huo J; Li B; Cui Y; Zhang H; Zhang L; Ma L
J Magn Reson Imaging; 2021 May; 53(5):1399-1407. PubMed ID: 33179832
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive Determination of
Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A
AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896
[TBL] [Abstract][Full Text] [Related]
15. Impact of signal intensity normalization of MRI on the generalizability of radiomic-based prediction of molecular glioma subtypes.
Foltyn-Dumitru M; Schell M; Rastogi A; Sahm F; Kessler T; Wick W; Bendszus M; Brugnara G; Vollmuth P
Eur Radiol; 2024 Apr; 34(4):2782-2790. PubMed ID: 37672053
[TBL] [Abstract][Full Text] [Related]
16. Prediction of IDH mutation status of glioma based on terahertz spectral data.
Sun Z; Wu X; Tao R; Zhang T; Liu X; Wang J; Wan H; Zheng S; Zhao X; Zhang Z; Yang P
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jul; 295():122629. PubMed ID: 36958244
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T
Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841
[TBL] [Abstract][Full Text] [Related]
19. Multimodel habitats constructed by perfusion and/or diffusion MRI predict isocitrate dehydrogenase mutation status and prognosis in high-grade gliomas.
Liu J; Cong C; Zhang J; Qiao J; Guo H; Wu H; Sang Z; Kang H; Fang J; Zhang W
Clin Radiol; 2024 Jan; 79(1):e127-e136. PubMed ID: 37923627
[TBL] [Abstract][Full Text] [Related]
20. Natural language processing to predict isocitrate dehydrogenase genotype in diffuse glioma using MR radiology reports.
Kim M; Ong KT; Choi S; Yeo J; Kim S; Han K; Park JE; Kim HS; Choi YS; Ahn SS; Kim J; Lee SK; Sohn B
Eur Radiol; 2023 Nov; 33(11):8017-8025. PubMed ID: 37566271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]